JTCS Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Hajime Ichikawa
Hikaru Matsuda
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sawa, Y.
Right arrow Articles by Matsuda, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sawa, Y.
Right arrow Articles by Matsuda, H.

J Thorac Cardiovasc Surg 1998;116:511-515
© 1998 Mosby, Inc.


Cardiopulmonary Support and Physiology

Interleukin-6 derived from hypoxic myocytes promotes neutrophil-mediated reperfusion injury in myocardium

Yoshiki Sawa, MD, Hajime Ichikawa, MD, Koji Kagisaki, MD, Toshihiro Ohata, MD, Hikaru Matsuda, MD

From the First Department of Surgery, Osaka University Medical School, Osaka, Japan.

Received for publication Dec 29, 1998. Revisions requested Feb 23, 1998; revisions received April 30, 1998. Accepted for publication May 13, 1998. Background: Reperfusion injury in the myocardium has recently been considered to be a type of inflammation, and close attention has been paid to the possible involvement of neutrophils, complement, and cytokines in the onset of this injury. Recently, it has been reported that serum levels of interleukin-6 are elevated significantly after myocardial infarction. The major site of interleukin-6 production and its exact roles are still unknown. In this study, we hypothesized that myocytes may produce interleukin-6 during hypoxia and this may play a role in neutrophil-mediated reperfusion injury.
Methods and results: In the clinical study, 20 patients who underwent coronary artery bypass grafting were divided into 2 groups: group F, in which patients were treated with a serine protease inhibitor (FUT-175, 2 mg/kg per hour) during cardiopulmonary bypass, and group C (untreated patients). In group C, myocardial interleukin-6 production, as determined by the difference between the interleukin-6 level in the cardiopulmonary bypass circuit and its level in coronary venous blood, increased significantly after reperfusion (12 ± 4 pg/mL) as compared with that before aortic crossclamping (2 ± 2 pg/mL). In group F, the increase in the interleukin-6 level was suppressed significantly (before aortic crossclamping, 3 ± 2 pg/mL; after reperfusion, 4 ± 3 pg/mL). The interleukin-6 production differed significantly between group C and group F. In the in vitro experimental study, the supernatant from myocytes exposed to 2 hours of hypoxia (group 2H) showed significantly higher levels of interleukin-6 (455 ± 260 pg/mL) than that from normoxic myocytes (group N) (47 ± 15 pg/mL). This interleukin-6 production was suppressed by the addition of FUT-175 (123 ± 24 pg/mL). The interleukin-6 production by endothelial cells of coronary vessels did not differ between group 2H (283 ± 151 pg/mL) and group N (151 ± 86 pg/mL). In a coincubation system with a monolayer of endothelial cells on collagen membrane and myocytes under collagen membrane in a modified Boyden chamber, 2 hours of coincubation showed a significantly higher percent of neutrophil transendothelial migration (group 2H vs N, 78% ± 13% vs 26% ± 11%), value of chemiluminescence (22 ± 8 vs 5 ± 2 x 103 counts/3 minutes), and percent of irreversibly damaged myocytes (48% ± 17% vs 12% ± 8%) than normoxic coincubation. In contrast, anti–interleukin-6 monoclonal antibody significantly attenuated neutrophil transendothelial migration (42% ± 19%) and irreversible damage of myocytes (26% ± 15%) in 2 hours of coincubation.
Conclusions: Interleukin-6 is produced from myocardium during ischemia and reperfusion in patients undergoing coronary bypass grafting. This interleukin-6 may be derived from hypoxic myocytes and play a role in neutrophil-mediated reperfusion injury in myocardium.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
A. S. Farivar, H. E. Merry, M. J. Fica-Delgado, A. S. McCourtie, B. C. Mackinnon-Patterson, and M. S. Mulligan
Interleukin-6 Regulation of Direct Lung Ischemia Reperfusion Injury
Ann. Thorac. Surg., August 1, 2006; 82(2): 472 - 478.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
K. Ishida, F. Kimura, M. Imamaki, A. Ishida, H. Shimura, H. Kohno, M. Sakurai, and M. Miyazaki
Relation of inflammatory cytokines to atrial fibrillation after off-pump coronary artery bypass grafting.
Eur. J. Cardiothorac. Surg., April 1, 2006; 29(4): 501 - 505.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
I. Ikonomidis, G. Athanassopoulos, J. Lekakis, K. Venetsanou, M. Marinou, K. Stamatelopoulos, D. V. Cokkinos, and P. Nihoyannopoulos
Myocardial Ischemia Induces Interleukin-6 and Tissue Factor Production in Patients With Coronary Artery Disease: A Dobutamine Stress Echocardiography Study
Circulation, November 22, 2005; 112(21): 3272 - 3279.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
X.-W. Yu, Q. Chen, R. H Kennedy, and S. J Liu
Inhibition of sarcoplasmic reticular function by chronic interleukin-6 exposure via iNOS in adult ventricular myocytes
J. Physiol., July 15, 2005; 566(2): 327 - 340.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. Vassilakopoulos, M. Divangahi, G. Rallis, O. Kishta, B. Petrof, A. Comtois, and S. N. A. Hussain
Differential Cytokine Gene Expression in the Diaphragm in Response to Strenuous Resistive Breathing
Am. J. Respir. Crit. Care Med., July 15, 2004; 170(2): 154 - 161.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Ryugo, Y. Sawa, M. Ono, Y. Miyamoto, A. N. Aleshin, and H. Matsuda
Pharmacologic preconditioning of JTE-607, a novel cytokine inhibitor, attenuates ischemia-reperfusion injury in the myocardium
J. Thorac. Cardiovasc. Surg., June 1, 2004; 127(6): 1723 - 1727.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Vinten-Johansen
Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury
Cardiovasc Res, February 15, 2004; 61(3): 481 - 497.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Yu, R. H. Kennedy, and S. J. Liu
JAK2/STAT3, Not ERK1/2, Mediates Interleukin-6-induced Activation of Inducible Nitric-oxide Synthase and Decrease in Contractility of Adult Ventricular Myocytes
J. Biol. Chem., April 25, 2003; 278(18): 16304 - 16309.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
A. Mazzone, J. Gianetti, E. Picano, S. Bevilacqua, G. Zucchelli, A. Biagini, and M. Glauber
Correlation between inflammatory response and markers of neuronal damage in coronary revascularization with and without cardiopulmonary bypass
Perfusion, January 1, 2003; 18(1): 3 - 8.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. Wan and A. P. C. Yim
Tai Ji: The law of inflammatory response
J. Thorac. Cardiovasc. Surg., December 1, 2002; 124(6): 1071 - 1073.
[Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
H. H. Hovels-Gurich, J. F. Vazquez-Jimenez, A. Silvestri, K. Schumacher, R. Minkenberg, J. Duchateau, B. J. Messmer, G. von Bernuth, and M.-C. Seghaye
Production of proinflammatory cytokines and myocardial dysfunction after arterial switch operation in neonates with transposition of the great arteries
J. Thorac. Cardiovasc. Surg., October 1, 2002; 124(4): 811 - 820.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Deten, H. C. Volz, W. Briest, and H.-G. Zimmer
Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats
Cardiovasc Res, August 1, 2002; 55(2): 329 - 340.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. D. Crittenden
Intraoperative metabolic monitoring of the heart: I. Clinical assessment of coronary sinus metabolites
Ann. Thorac. Surg., December 1, 2001; 72(6): S2220 - 2226.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
M. Redlin, J. Werner, H. Habazettl, W. Griethe, H. Kuppe, and A. R. Pries
Cariporide (HOE 642) Attenuates Leukocyte Activation in Ischemia and Reperfusion
Anesth. Analg., December 1, 2001; 93(6): 1472 - 1479.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Juvonen, F. Biancari, and J. Rimpilainen
Reply
J. Thorac. Cardiovasc. Surg., August 1, 2001; 122(2): 402 - 402.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. G. Wood, J. S. Johnson, L. F. Mattioli, and N. C. Gonzalez
Systemic hypoxia increases leukocyte emigration and vascular permeability in conscious rats
J Appl Physiol, October 1, 2000; 89(4): 1561 - 1568.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
W. J. Dreyer, S. C. Phillips, M. L. Lindsey, P. Jackson, N. E. Bowles, L. H. Michael, and M. L. Entman
Interleukin 6 induction in the canine myocardium after cardiopulmonary bypass
J. Thorac. Cardiovasc. Surg., August 1, 2000; 120(2): 256 - 263.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
Y. Okazaki, Z.-L. Cao, S. Ohtsubo, M. Hamada, K. Naito, K. Rikitake, M. Natsuaki, and T. Itoh
Leukocyte-depleted reperfusion after long cardioplegic arrest attenuates ischemia-reperfusion injury of the coronary endothelium and myocardium in rabbit hearts
Eur. J. Cardiothorac. Surg., July 1, 2000; 18(1): 90 - 97.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
D. F. Shen, M. A. Chang, D. M. Matteson, R. Buggage, A. T. Kozhich, and C.-C. Chan
Biphasic Ocular Inflammatory Response to Endotoxin-Induced Uveitis in the Mouse
Arch Ophthalmol, April 1, 2000; 118(4): 521 - 527.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
R. A. V. ANDEL, C. L. FRANKLIN, C. L. BESCH-WILLIFORD, and R. R. H. A. L. K. RILEY
Role of interleukin-6 in determining the course of murine Tyzzer's disease
J. Med. Microbiol., February 1, 2000; 49(2): 171 - 176.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
J. Grunenfelder, G. Zund, A. Schoeberlein, F. E. Maly, U. Schurr, S. Guntli, K. Fischer, and M. Turina
Modified ultrafiltration lowers adhesion molecule and cytokine levels after cardiopulmonary bypass without clinical relevance in adults
Eur. J. Cardiothorac. Surg., January 1, 2000; 17(1): 77 - 83.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
S. Wan and A. P.C. Yim
Cytokines in myocardial injury: impact on cardiac surgical approach
Eur. J. Cardiothorac. Surg., September 1, 1999; 16(suppl_1): S107 - S111.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Kogaki, Y. Sawa, T. Sano, T. Matsushita, T. Ohata, S. Kurotobi, S. J. Tojo, H. Matsuda, and S. Okada
Selectin on activated platelets enhances neutrophil endothelial adherence in myocardial reperfusion injury
Cardiovasc Res, September 1, 1999; 43(4): 968 - 973.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Wan, M. B. Izzat, T. W. Lee, I. Y.P. Wan, N. L.S. Tang, and A. P.C. Yim
Avoiding cardiopulmonary bypass in multivessel CABG reduces cytokine response and myocardial injury
Ann. Thorac. Surg., July 1, 1999; 68(1): 52 - 56.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Liebold, C. Keyl, and D. E. Birnbaum
The heart produces but the lungs consume proinflammatory cytokines following cardiopulmonary bypass
Eur. J. Cardiothorac. Surg., March 1, 1999; 15(3): 340 - 345.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1998 by The American Association for Thoracic Surgery.